Sales rise 29.20% to Rs 208.48 crore
Net profit of Astrazeneca Pharma India rose 57.94% to Rs 14.42 crore in the quarter ended September 2019 as against Rs 9.13 crore during the previous quarter ended September 2018. Sales rose 29.20% to Rs 208.48 crore in the quarter ended September 2019 as against Rs 161.36 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales208.48161.36 29 OPM %16.109.15 -PBDT36.4418.11 101 PBT31.8014.44 120 NP14.429.13 58Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
